Tower Research Capital (TRC)’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.3K Buy
+2,076
New +$30.6K ﹤0.01% 3189
2022
Q1
Sell
-2,271
Closed -$44K 6083
2021
Q4
$44K Buy
+2,271
New +$44.2K ﹤0.01% 2855
2021
Q1
Sell
-200
Closed -$4K 5392
2020
Q4
$4K Buy
+200
New +$4.24K ﹤0.01% 4686

Other funds holding BCAT

Tower Research Capital (TRC)'s BCAT Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in BlackRock Capital Allocation Term Trust (BCAT) in Q1 2026: 2,076 shares worth $29.3K. The stake represents ﹤0.01% of the portfolio and ranks #3189 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in BCAT as recently as Q4 2021.

Tower Research Capital (TRC) first reported a position in BCAT in Q4 2020 and has held it in 3 quarters since. The position peaked at $44K in Q4 2021. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

  • Tower Research Capital (TRC) held 2,076 shares of BlackRock Capital Allocation Term Trust worth $29.3K as of Q1 2026.
  • BlackRock Capital Allocation Term Trust was a new Tower Research Capital (TRC) position in Q1 2026.
  • BlackRock Capital Allocation Term Trust made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3189 holding.
  • Tower Research Capital (TRC) first reported a position in BlackRock Capital Allocation Term Trust in Q4 2020 and has held it in 3 quarters since.
  • Tower Research Capital (TRC)'s BlackRock Capital Allocation Term Trust position peaked at $44K in Q4 2021.
  • 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.